ML192 (MLS-000526305; ML-192; CID-1434953) is a novel and potent ligands for GPR55 with potential utility in treating behavioral disorders leading to conditions such as obesity. GPR55 has gained notoriety because of its putative identification as a cannabinoid receptor subtype.

纯度：≥98%

CAS：460331-61-7